Women's Health

Squaring Peace of Mind with Facts about Double Mastectomy

One in six women with early-stage unilateral breast cancer undergoes double mastectomy even when it is unlikely to provide a survival benefit, according to a recent Jama Surgery study.

A Snapshot of Women’s Health

A vast range of personal and sociocultural factors affect women’s well-being, making women’s health a field that is in a constant state of change.

Addressing an Information Gap on Breast Reconstruction

Breast reconstructive surgery candidates often are not well-informed about the procedure or the risk of complications, recent research suggests.

A Focus on Women

Recent data paint an alarming portrait of threats to women’s health.

The Peril of Quitting: Assessing the Risk of Ending Hormone Replacement Therapy

For many women, stopping hormone replacement therapy (HRT) may involve significant medical risk, recent research has found.

Research Highlights Benefit of Ovarian Tissue Transplantation after Cancer Treatment

Gonadal toxicity can be a side effect of chemotherapy and radiation therapy. However, a recent study in Denmark confirms what many physicians have suspected: Ovarian tissue cryopreservation and transplantation is a safe, effective method of preserving fertility.

Chemical in Ants and Plant Multiplies Benefit of Cancer Drug

Researchers at the University of Warwick in the United Kingdom have determined a chemical found naturally in ants and stinging nettles — a plant similar to poison ivy — multiplies the effectiveness of the cancer drug JS07 by 50 times.

New Findings May Allay Fear of Complications among Breast Reconstruction Patients

Research in the journal Plastic and Reconstructive Surgery challenges the traditional view that older women have a greater risk of complications following both implant-based and autologous breast reconstruction.

Portrait of a Woman

Take a glimpse at some key statistics related to women’s health.

Breast Cancer Drug Therapy Findings Alter Standard of Care

A breakthrough in research on human epidermal growth factor receptor 2 (HER2) positive breast cancer used a three-drug combination to produce median survivorship of more than four years.